JP2007500130A5 - - Google Patents

Download PDF

Info

Publication number
JP2007500130A5
JP2007500130A5 JP2006521278A JP2006521278A JP2007500130A5 JP 2007500130 A5 JP2007500130 A5 JP 2007500130A5 JP 2006521278 A JP2006521278 A JP 2006521278A JP 2006521278 A JP2006521278 A JP 2006521278A JP 2007500130 A5 JP2007500130 A5 JP 2007500130A5
Authority
JP
Japan
Prior art keywords
imidazol
triazolo
pyrimidine
ylmethyl
propyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006521278A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007500130A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2004/023794 external-priority patent/WO2005012306A2/en
Publication of JP2007500130A publication Critical patent/JP2007500130A/ja
Publication of JP2007500130A5 publication Critical patent/JP2007500130A5/ja
Pending legal-status Critical Current

Links

JP2006521278A 2003-07-25 2004-07-23 ベンゾジアゼピン受容体リガンドである、イミダゾ−ピリミジン及びトリアゾロ−ピリミジン Pending JP2007500130A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US49000603P 2003-07-25 2003-07-25
US54308304P 2004-02-09 2004-02-09
PCT/US2004/023794 WO2005012306A2 (en) 2003-07-25 2004-07-23 Imidazo-pyrimidines and triazolo-pyrimidines: benzodiazepine receptor ligands

Publications (2)

Publication Number Publication Date
JP2007500130A JP2007500130A (ja) 2007-01-11
JP2007500130A5 true JP2007500130A5 (https=) 2007-09-06

Family

ID=34118813

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006521278A Pending JP2007500130A (ja) 2003-07-25 2004-07-23 ベンゾジアゼピン受容体リガンドである、イミダゾ−ピリミジン及びトリアゾロ−ピリミジン

Country Status (20)

Country Link
US (2) US7271170B2 (https=)
EP (1) EP1648899B1 (https=)
JP (1) JP2007500130A (https=)
KR (1) KR20060098425A (https=)
AR (1) AR045117A1 (https=)
AT (1) ATE350382T1 (https=)
AU (1) AU2004261591A1 (https=)
BR (1) BRPI0412908A (https=)
CA (1) CA2537331A1 (https=)
CY (1) CY1107565T1 (https=)
DE (1) DE602004004143T2 (https=)
DK (1) DK1648899T3 (https=)
ES (1) ES2278345T3 (https=)
IL (1) IL173265A0 (https=)
MX (1) MXPA06000887A (https=)
NZ (1) NZ544262A (https=)
PL (1) PL1648899T3 (https=)
PT (1) PT1648899E (https=)
TW (1) TW200524937A (https=)
WO (1) WO2005012306A2 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7482366B2 (en) * 2001-12-21 2009-01-27 X-Ceptor Therapeutics, Inc. Modulators of LXR
CA2524376A1 (en) * 2003-05-05 2004-12-16 Neurogen Corporation Substituted imidazolopyrazine and triazolopyrazyne derivatives: gabaa receptor ligands
US20080167324A1 (en) * 2005-03-02 2008-07-10 Yuelian Xu Thiazolymethyl and Oxazolylmethyl Heteroaryl Derivatives
US7709468B2 (en) 2005-09-02 2010-05-04 Abbott Laboratories Imidazo based heterocycles
EP2146576A4 (en) * 2007-04-11 2013-01-16 Cypress Bioscience Inc TREATMENT OF DOWN SYNDROME WITH BENZODIAZEPINE REACTANT AGONISTS
US8546394B2 (en) 2007-04-17 2013-10-01 Bristol-Myers Squibb Company Substituted [1,2,4]triazolo[4,3-A]pyrazine 11-beta-hydroxysteroid dehydrogenase inhibitors
GB0719803D0 (en) 2007-10-10 2007-11-21 Cancer Rec Tech Ltd Therapeutic compounds and their use
US20090270373A1 (en) * 2008-04-11 2009-10-29 Cypress Biosciences, Inc. Treatment of down syndrom with benzodiazepine receptor antagonists

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US544057A (en) * 1895-08-06 Bill and letter file
AU4058000A (en) * 1999-04-02 2000-10-23 Neurogen Corporation Aryl and heteroaryl fused aminoalkyl-imidazole derivatives: selective modulatorsof gabaa receptors
US6737242B1 (en) * 1999-05-07 2004-05-18 Neurogen Corporation Methods for screening GABA-modulatory compounds for specified pharmacological activities
GB9929687D0 (en) * 1999-12-15 2000-02-09 Merck Sharp & Dohme Therapeutic agents
AU2001270297A1 (en) * 2000-06-30 2002-01-14 Neurogen Corporation 2-phenylimidazo(1,2-a)pyridine derivatives: a new class of gaba brain receptor ligands
GB0027561D0 (en) 2000-11-10 2000-12-27 Merck Sharp & Dohme Therapeutic agents
US6900215B2 (en) * 2000-12-15 2005-05-31 Merck Sharp & Dohme Ltd. Imidazo-pyrimidine derivatives as ligands for gaba receptors
PA8535601A1 (es) 2000-12-21 2002-11-28 Pfizer Derivados benzimidazol y piridilimidazol como ligandos para gabaa
TWI248936B (en) * 2001-03-21 2006-02-11 Merck Sharp & Dohme Imidazo-pyrimidine derivatives as ligands for GABA receptors
ATE338758T1 (de) 2001-03-23 2006-09-15 Merck Sharp & Dohme Imidazopyrimidin-derivate als liganden für gaba- rezeptoren
IL159811A0 (en) * 2001-07-13 2004-06-20 Neurogen Corp Heteroaryl substituted fused bicyclic heteroaryl compounds as gabaa receptor ligands
GB0128499D0 (en) * 2001-11-28 2002-01-23 Merck Sharp & Dohme Therapeutic agents
JP2005531548A (ja) * 2002-05-02 2005-10-20 ニューロジェン コーポレイション 置換イミダゾール誘導体:gabaa受容体リガンド
JP2006515278A (ja) * 2002-05-08 2006-05-25 ニューロジェン コーポレイション 置換イミダゾリルメチルピリジン及びピラジン誘導体並びにそれらのgabaa受容体リガンドとしての使用
DE60306918T2 (de) * 2002-05-17 2007-03-01 Neurogen Corp., Branford Substituierte, ringkondensierte imidazolderivate: gabaa-rezeptorliganden
CN100579579C (zh) * 2002-10-01 2010-01-13 诺华疫苗和诊断公司 抗癌及抗感染性疾病组合物及其使用方法
ATE335732T1 (de) 2002-11-08 2006-09-15 Neurogen Corp 4-imidazol-1-ylmethylpyrimidinderivate als liganden für gabaa-rezeptoren
CA2524376A1 (en) 2003-05-05 2004-12-16 Neurogen Corporation Substituted imidazolopyrazine and triazolopyrazyne derivatives: gabaa receptor ligands

Similar Documents

Publication Publication Date Title
US11964961B2 (en) Heteroaromatic compounds and their use as dopamine D1 ligands
ES2649144T3 (es) Compuestos heteroaromáticos y su uso como ligandos de dopamina D1
AU2013343105B2 (en) Heteroaromatic compounds as dopamine D1 ligands
JP2024123079A (ja) トリアゾロ-ピリミジン化合物およびそれらの使用
US9688698B2 (en) Heteroaromatic compounds and their use as dopamine D1 ligands
US10077272B2 (en) Heteroaromatic compounds and their use as dopamine D1 ligands
WO2015166370A1 (en) Heteroaromatic compounds and their use as dopamine d1 ligands
JP2007500130A5 (https=)
OA18107A (en) Heteroaromatic compounds and their use as dopamine D1 ligands